Zobrazeno 1 - 7
of 7
pro vyhledávání: '"E. F. Shevtsova"'
Autor:
N. A. Lozinskaya, A. A. Morozov, D. R. Bazanov, E. R. Milaeva, D. A. Areshidze, P. N. Shevtsov, L. N. Petrova, E. F. Shevtsova
Publikováno v:
Безопасность и риск фармакотерапии, Vol 11, Iss 2, Pp 165-175 (2023)
Most of the medicinal products that are currently approved and used in clinical practice for neurodegenerative diseases, in particular Alzheimer’s disease, have a compensatory mechanism of action that enhances neurotransmitter signalling. It is an
Externí odkaz:
https://doaj.org/article/46eb329755eb4631add02a51b7a99525
Autor:
E. R. Milaeva, S. I. Filimonova, N. N. Meleshonkova, L. G. Dubova, E. F. Shevtsova, S. O. Bachurin, N. S. Zefirov
Publikováno v:
Bioinorganic Chemistry and Applications, Vol 2010 (2010)
The antioxidative activity of ferrocenes bearing either 2,6-di-tert-butylphenol or phenyl groups has been compared using DPPH (1,1-diphenyl-2-picrylhydrazyl) test and in the study of the in vitro impact on lipid peroxidation in rat brain homogenate a
Externí odkaz:
https://doaj.org/article/33186562b19042d78995ef41db4a07a2
Publikováno v:
Russian Chemical Bulletin. 72:130-147
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5fce770f11cfdc4d13f68562fa23944b
https://doi.org/10.1007/s11172-023-3718-0
https://doi.org/10.1007/s11172-023-3718-0
Autor:
N. A. Zefirov, P. D. Korotkova, E. F. Shevtsova, P. N. Shevtsov, A. V. Mamaeva, E. R. Milaeva, O. N. Zefirova
Publikováno v:
Russian Chemical Bulletin. 71:2519-2524
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da1276b7303067d950865afd148fbf22
https://doi.org/10.1007/s11172-022-3682-0
https://doi.org/10.1007/s11172-022-3682-0
Autor:
G. F. Makhaeva, E. F. Shevtsova, N. P. Boltneva, N. V. Kovaleva, E. V. Rudakova, L. G. Dubova, P. N. Shevtsov, S. O. Bachurin
Publikováno v:
Доклады Академии наук. 484:104-108
This study presents the synthesis of binary tetrohydro-γ-carbolines with ditriazol spacers of varying length, which exhibit anticholinesterase and antioxidant activity, as compared to the original Dimebon prototype. Anticholinesterase activity sugge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c1c63bf9cb3827ecd3d44357a115ba8
https://doi.org/10.31857/s0869-56524841104-108
https://doi.org/10.31857/s0869-56524841104-108
Publikováno v:
Vestnik Rossiiskoi akademii meditsinskikh nauk. (9)
Contemporary methods of treatment of neurodegenerative diseases (NDs) are limited and mainly symptomatic. Despite difference in particular clinical manifestations, NDs have a number of common features, the main of which is death of certain neuron pop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::121f0311cf4da7f40464e564c0e8a9da
https://pubmed.ncbi.nlm.nih.gov/16250325
https://pubmed.ncbi.nlm.nih.gov/16250325
Publikováno v:
Bulletin of experimental biology and medicine. 132(5)
Dimebon, a Russian-made drug, inhibited toxic effects of beta -amyloid on cultured neurons. Excessive accumulation of beta-amyloid in the brain is characteristic of Alzheimer dementias. Antialzheimer preparations tacrine and dimebon improve survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::08b7575ea5c5b429b61c0c2fd21a7136
https://pubmed.ncbi.nlm.nih.gov/11865327
https://pubmed.ncbi.nlm.nih.gov/11865327